Aktiesnakken — Juni 2013
-
RBJ der har været en ADC, Teprotumumab, Fabrikssalget som vel ihvertfald kan kaldes aftaler
-
Er dog enig i at han stadig skylder mindst en DuoBody aftale
-
Chartet ligner jo også stadig lort.
-
-
Det er jo en kunde der sælger og bowers der laver analysen
-
der behøver ikke være sammenhæng
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind